Medrad signs distribution pact

Contrast injector technology firm Medrad of Warrendale, PA, has signed an exclusive distribution agreement with WFR-Aquaplast/Qfix Systems for the company's Pro-Tekt endorectal balloon device.

The Pro-Tekt device is designed to immobilize structures that surround the rectum, such as the prostate, for radiation therapy treatment.

The device currently is available to healthcare providers throughout the U.S., Australia, and Europe.

Related Reading

Medrad gets FDA OK for Intego, July 7, 2010

Medrad inks PET deal with MGH, June 7, 2010

Medrad, Pinestar team up, May 19, 2010

Medrad opens US probe service center, March 24, 2010

Medrad to launch contrast IT platform, November 23, 2009

Copyright © 2010 AuntMinnie.com

Page 1 of 179
Next Page